The RNA‐binding protein ZFP36 strengthens innate antiviral signaling by targeting RIG‐I for K63‐linked ubiquitination

Author:

Jiang Xue1,Xiao Yanping1,Hou Wen1,Yu Jingge2,He Tian‐Sheng12ORCID,Xu Liang‐Guo1ORCID

Affiliation:

1. College of Life Science Jiangxi Normal University Nanchang Jiangxi China

2. School of Basic Medicine Gannan Medical University Ganzhou Jiangxi China

Abstract

AbstractInnate immunity is the first line of defense against infections, which functions as a significant role in resisting pathogen invasion. Rapid immune response is initiated by pattern recognition receptors (PRRs) quickly distinguishing “self” and “non‐self.” Upon evolutionarily conserved pathogen‐associated molecular pattern (PAMP) is recognized by PRRs, innate immune response against infection is triggered via an orchestration of molecular interaction, cytokines cascades, and immune cells. RIG‐I plays a critical role in type I interferon (IFN‐I) production by direct recognition of cytoplasmic double‐stranded viral RNA. However, the activation mechanism of RIG‐I is incompletely understood. In this study, we reported RNA‐binding protein ZFP36 as a positive regulator of RIG‐I‐mediated IFN‐I production. ZFP36 is a member of Zinc finger proteins (ZFPs) characterized by the zinc finger (ZnF) motif, which broadly involved gene transcription and signal transduction. However, its role in regulating antiviral innate immune signaling is still unclear. We found that ZFP36 associates with RIG‐I and potentiates the FN‐β production induced by SeV. Mechanistically, ZFP36 promotes K63‐linked polyubiquitination of RIG‐I, mostly at K154/K164/K172, thereby facilitating the activation of RIG‐I during infection. While the mutant ZFP36 (C118S/C162S) failed to increase polyubiquitination of RIG‐I and SeV induced FN‐β. Our findings collectively demonstrated that ZFP36 acts as a positive regulator in antiviral innate immunity by targeting RIG‐I for K63‐linked ubiquitination, thus improving our understanding of the activation mechanism of RIG‐I.

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3